Ronald J Buckanovich (Ron Bukanovich)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Chemotherapy Induced

Regulatory T Cells

Palliative Care

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Science advances

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (21) (2024)
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker, Paul A DiSilvestro, Cara A Mathews, David G Mutch, Marcia L Hernandez, Lainie P Martin, Erin Bishop, Sarah E Gill, Mary E Gordinier, Robert A Burger, Carol Aghajanian, Joyce F Liu, Kathleen M Moore, Michael A Bookman
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Alexander J Cole, Santiago Panesso-Gomez, Jaynish S Shah, Tonge Ebai, Qi Jiang, Ece Gumusoglu, Maya G Bello, Anda M Vlad, Francesmary Modugno, Robert P Edwards, Ronald J Buckanovich
Quiescent ovarian cancer cells secrete follistatin to induce chemotherapy resistance in surrounding cells in response to chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sarah E Taylor, Daniel K Chan, Dongli Yang, Tulia Bruno, Richard Lieberman, Javed Siddiqui, Thing Rinda Soong, Lan G Coffman, Ronald J Buckanovich
Shifting the Soil: Metformin Treatment Decreases the Protumorigenic Tumor Microenvironment in Epithelial Ovarian Cancer. Cancers 14 (9) (2022)
Shoumei Bai, Sarah E Taylor, Mohd Azrin Jamalruddin, Stacy McGonigal, Edward Grimley, Dongli Yang, Kara A Bernstein, Ronald J Buckanovich
Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian Cancer. Molecular cancer therapeutics 21 (9) (2022)
Christopher A Chuckran, Anthony R Cillo, Jessica M Moskovitz, Abigail Overacre-Delgoffe, Ashwin S Somasundaram, Feng Shan, Grant C Magnon, Sheryl R Kunning, Irina Abecassis, Amer H Zureikat, James D Luketich, Arjun Pennathur, John Charles Sembrat, Mauricio Rojas, Daniel T Merrick, Sarah E Taylor, Brian C Orr, Francesmary Modugno, Ronald J Buckanovich, Robert E Schoen, Seungwon Kim, Umamaheswar Duvvuri, Herbert J Zeh, Robert Edwards, Joanne M Jeter, Lan G Coffman, Robert L Ferris, Tullia C Bruno, Dario A A Vignali
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer. Science translational medicine 13 (623) (2021)
Sandra Cascio, Chelsea Chandler, Linan Zhang, Sarah Sinno, Bingsi Gao, Sayali S Onkar, Tullia C Bruno, Dario A A Vignali, Haider Mahdi, Hatice U Osmanbeyoglu, Anda M Vlad, Lan G Coffman, Ronald J Buckanovich
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition. Science advances 7 (46) (2021)
Mikhail S Chesnokov, Imran Khan, Yeonjung Park, Jessica Ezell, Geeta Mehta, Abdelrahman Yousif, Linda J Hong, Ronald J Buckanovich, Akimasa Takahashi, Ilana Chefetz
The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma. Cancers 13 (6) (2021)
Erin G Hartnett, Julia Knight, Mackenzy Radolec, Ronald J Buckanovich, Robert P Edwards, Anda M Vlad
Immunotherapy Advances for Epithelial Ovarian Cancer. Cancers 12 (12) (2020)